APA (7th ed.) Citation

Pratt, A., Siebert, S., Cole, M., Stocken, D., Kelly, S., Shaikh, M., . . . Isaacs, J. D. (2020). AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases, 79(Suppl 1), 1478. https://doi.org/10.1136/annrheumdis-2020-eular.2443

Chicago Style (17th ed.) Citation

Pratt, A., et al. "AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases 79, no. Suppl 1 (2020): 1478. https://doi.org/10.1136/annrheumdis-2020-eular.2443.

MLA (9th ed.) Citation

Pratt, A., et al. "AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases, vol. 79, no. Suppl 1, 2020, p. 1478, https://doi.org/10.1136/annrheumdis-2020-eular.2443.